Brenda Galindo-Yllu

Brenda Galindo-Yllu

Auto-generated profile, based on publicly available information

Brenda Galindo-Yllu

Unidad de Investigación Clínica y Epidemiológica, Escuela de Medicina, Universidad Peruana Unión, Lima, Peru

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2022 in Journal of Nutrition and Metabolism
Verified
Journal Article
Open access
PDF file
RRRicardo Rojas-Humpire
Ricardo Rojas-Humpire
DSDavid R. Soriano-Moreno
David R. Soriano-Moreno
BGBrenda Galindo-Yllu
Brenda Galindo-Yllu
JZJessica Hanae Zafra-Tanaka
Jessica Hanae Zafra-Tanaka
Background . Copeptin, a reliable marker for vasopressin release, has been associated with cardiometabolic diseases including metabolic syndrome (MetS). This systematic review aims to evaluate the association between copeptin and MetS. Methods . We searched in Pubmed, Scopus, EMBASE, and Web of Science databases until March 2021 and included observational studies (cohort studies, cross‐sectional, and case‐control) reporting the risk or prevalence of having MetS in patients with elevated copeptin levels compared to patients without elevated copeptin levels. The risk of bias was evaluated with the Newcastle‐Ottawa Scale. Meta‐analysis was not performed because of the heterogeneity of the copeptin cut‐off values. Results . A total of 7 studies (5 cross‐sectional, 1 case‐control, and 1 cohort) were included comprising 11,699 participants. Most of them were performed in the adult general population. Two cross‐sectional and one case‐control studies found a positive significant association between higher levels of copeptin and MetS. While three cross‐sectional and one cohort studies found no association. The case‐control study had several methodological limitations, most cross‐sectional studies were methodologically adequate and the cohort study had no methodological issues. Conclusions . The association between copeptin and MetS is inconsistent. However, the arginine‐vasopressin system impairment contributes to metabolic disorders, expressing plasma copeptin changes. Thus, more longitudinal studies are required to corroborate the association of copeptin and MetS.

30 June 2026 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
RCRoger De la Cerna-Luna
Roger De la Cerna-Luna
AAAlexander G. Acevedo-Cahuana
Alexander G. Acevedo-Cahuana
BGBrenda Galindo-Yllu
Brenda Galindo-Yllu
EZElvira G. Zamora-Huaringa
Elvira G. Zamora-Huaringa
MRMabel Ramirez-Chipana
Mabel Ramirez-Chipana
PMPilar Merino-Orbegoso
Pilar Merino-Orbegoso
Con el objetivo de describir las características y comparar la necesidad con la utilización previa de servicios de rehabilitación en niños con parálisis cerebral en un hospital de referencia en Perú, se realizó un estudio descriptivo mediante la revisión de historias clínicas de 86 pacientes atendidos durante el 2024. Se encontró que el 41,8% no asistía a ninguna institución educativa y el 44,2% no contaba con certificado de discapacidad; entre quienes lo tenían, la media de tiempo para su obtención fue de 4,9 años. Menos de la mitad contaba con radiografía de pelvis, a pesar de que la luxación de cadera fue una comorbilidad frecuente. Aunque la mayoría requería terapias de rehabilitación, su cobertura fue limitada, especialmente en terapia ocupacional y de lenguaje/deglución. Asimismo, más de la mitad de quienes requerían toxina botulínica no la habían recibido. Estos hallazgos evidencian importantes discrepancias entre la necesidad y la utilización previa de servicios de rehabilitación en esta población.